Theriva Biologics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 450.26 K | $88.16 K | 112.30% | 3.71% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 253.22 K | $50.00 K | 100.00% | 2.09% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 241.78 K | $47.39 K | 100.00% | 1.99% |
| UBS GROUP AG | 05/05/2026 | 225.62 K | $44.22 K | 17.87% | 1.86% |
| 05/15/2026 | 192.40 K | $37.71 K | 100.00% | 1.58% | |
| JANE STREET GROUP, LLC | 05/12/2026 | 177.03 K | $34.66 K | 100.00% | 1.46% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 112.08 K | $21.94 K | 0.00% | 0.92% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 105.24 K | $20.61 K | 145.36% | 0.87% |
| XTX TOPCO LTD | 05/15/2026 | 94.62 K | $18.53 K | 139.88% | 0.78% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 27.65 K | $5.41 K | 0.00% | 0.23% |
| MORGAN STANLEY | 05/15/2026 | 23.60 K | $4.62 K | -88.20% | 0.19% |
| STONEX GROUP INC. | 05/14/2026 | 22.28 K | $4.36 K | -40.13% | 0.18% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 15.44 K | $3.02 K | -63.53% | 0.13% |
| SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS LLC | 05/08/2026 | 15.00 K | $2.94 K | 0.00% | 0.12% |
| BLACKROCK, INC. | 05/13/2026 | 7.50 K | $1.47 K | 0.00% | 0.06% |
| CITIGROUP INC | 05/11/2026 | 1.39 K | $272 | -77.52% | 0.01% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 131 | $26 | 122.03% | 0.00% |
| IFP ADVISORS, INC | 04/13/2026 | 11 | $2 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 8 | $1 | -98.21% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/05/2026 | 5 | $1 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Theriva Biologics Inc institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Theriva Biologics Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 450,263
Virtu Financial LLC: 253,218
VANGUARD FIDUCIARY TRUST CO: 241,780
UBS Group AG: 225,624
JANE STREET GROUP, LLC: 177,034
Ikarian Capital, LLC: 112,076
16.19% of Theriva Biologics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 2.22 M shares in the last 24 months. This purchase volume represents approximately $399.22 K in transactions.